GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (NAS:EMBC) » Definitions » Price-to-Tangible-Book

Embecta (Embecta) Price-to-Tangible-Book : (As of Jun. 02, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Embecta Price-to-Tangible-Book?

As of today (2024-06-02), Embecta's share price is $12.37. Embecta's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $-13.77. Hence, Embecta's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Embecta's Price-to-Tangible-Book or its related term are showing as below:

EMBC's Price-to-Tangible-Book is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.68
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Embecta's share price is $12.37. Embecta's Book Value per Sharefor the quarter that ended in Mar. 2024 was $-13.35. Hence, Embecta's P/B Ratio of today is .


Embecta Price-to-Tangible-Book Historical Data

The historical data trend for Embecta's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Price-to-Tangible-Book Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23
Price-to-Tangible-Book
- - - - -

Embecta Quarterly Data
Sep19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Embecta's Price-to-Tangible-Book

For the Medical Instruments & Supplies subindustry, Embecta's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embecta's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embecta's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Embecta's Price-to-Tangible-Book falls into.



Embecta Price-to-Tangible-Book Calculation

Embecta's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=12.37/-13.765
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Embecta Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Embecta's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Embecta (Embecta) Business Description

Traded in Other Exchanges
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
Executives
David F Melcher director 1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102
Devdatt Kurdikar officer: President and CEO ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Jacob Elguicze officer: Chief Financial Officer ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Jeffrey Z Mann officer: SVP, GC, Head Corp. Dev., Secy 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Jean Casner officer: Chief Human Resources Officer 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Karen Prange director 1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316
Ajay Kumar officer: SVP and CHRO C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Shaun Curtis officer: SVP, Global Manuf./Sup. Chain C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
David Albritton director ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417-1880
Milton Mayo Morris director 2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019
Brian Capone officer: VP, CAO & Corp. Controller 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Carrie L Anderson director 3005 HIGHLAND PARKWAY, SUITE 200, DOWNERS GROVE IL 60515
Claire Pomeroy director BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Christopher R Reidy director ONE ADP BLVD, ROSELAND NJ 07068
Robert J. Hombach director C/O BAXALTA INCORPORATED, 1200 LAKESIDE DRIVE, BANNOCKBURN IL 60015

Embecta (Embecta) Headlines

From GuruFocus

embecta opens new global headquarters in Parsippany, N.J.

By Stock market mentor Stock market mentor 01-25-2023

embecta to Participate in Upcoming Investor Conferences

By sperokesalga sperokesalga 02-08-2023

UPDATE -- embecta to Participate in Investor Conferences

By sperokesalga sperokesalga 05-15-2023

embecta to Report Fiscal First Quarter 2023 Financial Results

By Stock market mentor Stock market mentor 01-24-2023

embecta Announces Quarterly Cash Dividend

By sperokesalga sperokesalga 05-12-2023

embecta to Report Fiscal First Quarter 2023 Financial Results

By GlobeNewswire GlobeNewswire 01-24-2023

embecta to Participate in Investor Conferences

By sperokesalga sperokesalga 05-15-2023

Embecta Corp's Dividend Analysis

By GuruFocus Research 12-01-2023